(Total Views: 257)
Posted On: 02/20/2020 12:06:20 PM
Post# of 23602
$CURR Breaking through the controlled substance stigma to deliver new treatment paradigms Jessica Rousset, COO, CURE Pharmaceutical.
With the first FDA-approved cannabis extract (Epidiolex) emerging from the stigma of recreational cannabis, the pharmaceutical industry has taken notice of the potential therapeutic uses of scheduled drugs with no currently accepted medical use, says Jessica Rousset, COO at CURE Pharmaceutical. https://www.cphi.com/northamerica/en/about/ne...-2020.html
With the first FDA-approved cannabis extract (Epidiolex) emerging from the stigma of recreational cannabis, the pharmaceutical industry has taken notice of the potential therapeutic uses of scheduled drugs with no currently accepted medical use, says Jessica Rousset, COO at CURE Pharmaceutical. https://www.cphi.com/northamerica/en/about/ne...-2020.html
(0)
(0)Scroll down for more posts ▼
